Paysign, Inc. PAYS
9.79 USD -0.27 (-2.68%)
Regular-session close
9.58 -0.21 -2.17%
After hours · Nov 20, 6:13 PM ET
9.22 Day range 10.60
3.18 52-week range 15.62
- YTD
- +90.10%
- 1 year
- +93.86%
News
fool.com Paysign: 3 Key Takeaways for Long-Term Investors Pharma patient affordability revenue grew 110% year-over-year to $16.6 million. Losing 113 plasma centers reduces fourth-quarter revenue by $1.5 million.
zacks.com Is Paysign (PAYS) a Solid Growth Stock? 3 Reasons to Think "Yes" Paysign (PAYS) possesses solid growth attributes, which could help it handily outperform the market.
zacks.com All You Need to Know About Paysign (PAYS) Rating Upgrade to Buy Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com Down 39.2% in 4 Weeks, Here's Why Paysign (PAYS) Looks Ripe for a Turnaround Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising…
seekingalpha.com Paysign's Post-Q3 Selloff Opens An Opportunity Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a…benzinga.com Ladenburg Thalmann Maintains Buy on PaySign, Raises Price Target to $15.25 Ladenburg Thalmann analyst Jon Hickman maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $14 to $15.25.
benzinga.com DA Davidson Maintains Buy on PaySign, Lowers Price Target to $14 DA Davidson analyst Peter Heckmann maintains PaySign (NASDAQ:PAYS) with a Buy and lowers the price target from $15 to $14.
seekingalpha.com Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript
marketbeat.com Paysign Q3 Earnings Call Highlights Paysign NASDAQ: PAYS reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment…
benzinga.com PaySign Q3 2026 Earnings Call Transcript PaySign (NASDAQ:PAYS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com PaySign Raises FY2026 GAAP EPS Guidance from $0.35-$0.37 to $0.37-$0.38 vs $0.34 Est; Affirms FY2026 Sales Guidance of $114.000M-$117.000M vs $114.659M Est PaySign (NASDAQ:PAYS) raises FY2026 GAAP EPS guidance from $0.35-$0.37 to $0.37-$0.38 vs $0.34 analyst estimate. Affirms FY2026 sales outlook from $114.000 million-$117.000 million to $114.000…
benzinga.com PaySign Q3 EPS $0.11 Beats $0.09 Estimate, Sales $30.800M Beat $29.019M Estimate PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 175 percent increase over earnings of $0.04 per…
businesswire.com Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8% HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment…
seekingalpha.com Post-Election Hidden Gems: 3 Under-The-Radar Growth Stocks Favorable post-midterm election momentum, plus annual market seasonality accelerating with Black Friday, could provide powerful tailwinds for equities. Meanwhile, extreme market fear and…
gurufocus.com PaySign Inc (PAYS) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 62/100 On October 19, 2026, PaySign Inc (PAYS) shares rose 3.6% to $15.34, continuing a notable upward trend with a 52-week range of $3.08 to $15.80. The stock has sho
defenseworld.net Paysign (NASDAQ:PAYS) Reaches New 12-Month High – Here’s What Happened Paysign, Inc. (NASDAQ: PAYS - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday. The stock traded as high as $15.62 and last traded at $15.48, with a volume of 799,987…
businesswire.com Paysign to Host Third Quarter 2026 Earnings Call HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated…
defenseworld.net Paysign (NASDAQ:PAYS) Hits New 52-Week High – Still a Buy? Paysign, Inc. (NASDAQ: PAYS - Get Free Report)'s stock price reached a new 52-week high on Thursday. The company traded as high as $15.09 and last traded at $14.95, with a volume of 873426 shares…
seekingalpha.com Beyond Bank Earnings: 4 Best Financial Stocks For Rising Rates The best financial stocks to combat rising rates and inflation in Q4 may be those with superior growth and momentum, not traditional banks and brokerages. Persistent inflation and elevated interest…
defenseworld.net Bank of America Corp DE Makes New $335,000 Investment in Paysign, Inc. $PAYS Bank of America Corp DE purchased a new position in Paysign, Inc. (NASDAQ: PAYS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.…
defenseworld.net Paysign (NASDAQ:PAYS) Shares Climb 7.1% – Here’s Why Paysign, Inc. (NASDAQ: PAYS - Get Free Report)'s share price rose 7.1% during mid-day trading on Thursday. The stock traded as high as $14.27 and last traded at $14.44. Approximately 201,540 shares…
defenseworld.net BlackRock Inc. Buys Shares of 3,079,208 Paysign, Inc. $PAYS BlackRock Inc. bought a new position in Paysign, Inc. (NASDAQ: PAYS) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
marketbeat.com Paysign Targets $117M Revenue as Patient-Affordability Business Surges Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said…
zacks.com Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
zacks.com Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock? Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
